The pro-resolving lipid mediator maresin 1 (MaR1) attenuates inflammatory signaling pathways in vascular smooth muscle and endothelial cells

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Chatterjee, Anuran ^a   Sharma, Anjali ^a   Chen, Mian ^a   Toy, Robert ^a   Mottola, Giorgio ^a   Conte, Michael S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEINS AND BINDING PROTEINS; CYCLIC AMP; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; I KAPPA B ALPHA; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MARESIN 1; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; 7,14-DIHYDROXYDOCOSA-4,8,10,12,16,19-HEXAENOIC ACID; DOCOSAHEXAENOIC ACID; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CELL SURFACE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE ASSOCIATION; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; INFLAMMATION; NONHUMAN; OXIDATIVE STRESS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS REGULATION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; UPREGULATION; VASCULAR SMOOTH MUSCLE; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; METABOLISM; PHOSPHORYLATION; U937 CELL LINE;

CELL ADHESION; CELLS, CULTURED; CYCLIC AMP; DOCOSAHEXAENOIC ACIDS; DOWN-REGULATION; E-SELECTIN; ENDOTHELIAL CELLS; HUMANS; MUSCLE, SMOOTH, VASCULAR; NADPH OXIDASE; NF-KAPPA B; OXIDATIVE STRESS; PHOSPHORYLATION; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA; U937 CELLS; UP-REGULATION;

EID: 84914703674     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0113480     Document Type: Article

References (40)

1. Serhan CN, Clish CB, Brannon J, Colgan SP, Chiang N, et al. (2000) Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J Exp Med 192: 1197-1204.
2. Serhan CN, Yang R, Martinod K, Kasuga K, Pillai PS, et al. (2009) Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions. J Exp Med 206: 15-23.
3. Serhan CN, Dalli J, Karamnov S, Choi A, Park CK, et al. (2012) Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls pain. Faseb J 26: 1755-1765.
4. Serhan CN (2014) Pro-resolving lipid mediators are leads for resolution physiology. Nature 510: 92-101.
5. Fredman G, Serhan CN (2011) Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution. Biochem J 437: 185-197.
6. Lee CH (2012) Resolvins as new fascinating drug candidates for inflammatory diseases. Arch Pharm Res 35: 3-7.
7. Miyahara T, Runge S, Chatterjee A, Chen M, Mottola G, et al. (2013) D-series resolvin attenuates vascular smooth muscle cell activation and neointimal hyperplasia following vascular injury. Faseb J 27: 2220-2232.
8. Nordgren TM, Heires AJ, Wyatt TA, Poole JA, Levan TD, et al. (2013) Maresin-1 reduces the pro-inflammatory response of bronchial epithelial cells to organic dust. Respir Res 14: 51.
9. Marcon R, Bento AF, Dutra RC, Bicca MA, Leite DF, et al. (2013) Maresin 1, a proresolving lipid mediator derived from omega-3 polyunsaturated fatty acids, exerts protective actions in murine models of colitis. J Immunol 191: 4288-4298.
10. Dalli J, Serhan CN (2012) Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators. Blood 120: e60-72.
11. Wang GJ, Sui XX, Simosa HF, Jain MK, Altieri DC, et al. (2005) Regulation of vein graft hyperplasia by survivin, an inhibitor of apoptosis protein. Arterioscler Thromb Vasc Biol 25: 2081-2087.
12. Patricia MK, Kim JA, Harper CM, Shih PT, Berliner JA, et al. (1999) Lipoxygenase products increase monocyte adhesion to human aortic endothelial cells. Arterioscler Thromb Vasc Biol 19: 2615-2622.
13. Benov L, Sztejnberg L, Fridovich I (1998) Critical evaluation of the use of hydroethidine as a measure of superoxide anion radical. Free Radic Biol Med 25: 826-831.
14. Grabner R, Till U, Heller R (2000) Flow cytometric determination of E-selectin, vascular cell adhesion molecule-1, and intercellular cell adhesion molecule-1 in formaldehyde-fixed endothelial cell monolayers. Cytometry 40: 238-244.
15. De Keulenaer GW, Alexander RW, Ushio-Fukai M, Ishizaka N, Griendling KK (1998) Tumour necrosis factor alpha activates a p22phox-based NADH oxidase in vascular smooth muscle. Biochem J 329 (Pt 3): 653-657.
16. Lee IT, Luo SF, Lee CW, Wang SW, Lin CC, et al. (2009) Overexpression of HO-1 protects against TNF-alpha-mediated airway inflammation by downregulation of TNFR1-dependent oxidative stress. Am J Pathol 175: 519-532.
17. Moe KT, Aulia S, Jiang F, Chua YL, Koh TH, et al. (2006) Differential upregulation of Nox homologues of NADPH oxidase by tumor necrosis factoralpha in human aortic smooth muscle and embryonic kidney cells. J Cell Mol Med 10: 231-239.
18. Goyal P, Weissmann N, Rose F, Grimminger F, Schafers HJ, et al. (2005) Identification of novel Nox4 splice variants with impact on ROS levels in A549 cells. Biochem Biophys Res Commun 329: 32-39.
19. Sana TR, Janatpour MJ, Sathe M, McEvoy LM, McClanahan TK (2005) Microarray analysis of primary endothelial cells challenged with different inflammatory and immune cytokines. Cytokine 29: 256-269.
20. Zhao B, Stavchansky SA, Bowden RA, Bowman PD (2003) Effect of interleukin-1beta and tumor necrosis factor-alpha on gene expression in human endothelial cells. Am J Physiol Cell Physiol 284: C1577-1583.
21. Bandman O, Coleman RT, Loring JF, Seilhamer JJ, Cocks BG (2002) Complexity of inflammatory responses in endothelial cells and vascular smooth muscle cells determined by microarray analysis. Ann N Y Acad Sci 975: 77-90.
22. Napetschnig J, Wu H (2013) Molecular basis of NF-kappaB signaling. Annu Rev Biophys 42: 443-468.
23. DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E, Karin M (1997) A cytokine-responsive IkappaB kinase that activates the transcription factor NFkappaB. Nature 388: 548-554.
24. Sands WA, Palmer TM (2005) Inhibition of pro-inflammatory cytokine receptor signalling by cAMP in vascular endothelial cells. Biochem Soc Trans 33: 1126-1128.
25. Gusan S, Anand-Srivastava MB (2013) cAMP attenuates the enhanced expression of Gi proteins and hyperproliferation of vascular smooth muscle cells from SHR: role of ROS and ROS-mediated signaling. Am J Physiol Cell Physiol 304: C1198-1209.
26. Ho KJ, Spite M, Owens CD, Lancero H, Kroemer AH, et al. (2010) Aspirintriggered lipoxin and resolvin E1 modulate vascular smooth muscle phenotype and correlate with peripheral atherosclerosis. Am J Pathol 177: 2116-2123.
27. Van Buul JD, Fernandez-Borja M, Anthony EC, Hordijk PL (2005) Expression and localization of NOX2 and NOX4 in primary human endothelial cells. Antioxid Redox Signal 7: 308-317.
28. Lee HN, Surh YJ (2013) Resolvin D1-mediated NOX2 inactivation rescues macrophages undertaking efferocytosis from oxidative stress-induced apoptosis. Biochem Pharmacol 86: 759-769.
29. Takamiya R, Fukunaga K, Arita M, Miyata J, Seki H, et al. (2012) Resolvin E1 maintains macrophage function under cigarette smoke-induced oxidative stress. FEBS Open Bio 2: 328-333.
30. Krishnamoorthy S, Recchiuti A, Chiang N, Yacoubian S, Lee CH, et al. (2010) Resolvin D1 binds human phagocytes with evidence for proresolving receptors. Proc Natl Acad Sci U S A 107: 1660-1665.
31. Martin N, Ruddick A, Arthur GK, Wan H, Woodman L, et al. (2012) Primary human airway epithelial cell-dependent inhibition of human lung mast cell degranulation. PLoS One 7: e43545.
32. Mizwicki MT, Liu G, Fiala M, Magpantay L, Sayre J, et al. (2013) 1alpha, 25-dihydroxyvitamin D3 and resolvin D1 retune the balance between amyloid-beta phagocytosis and inflammation in Alzheimer's disease patients. J Alzheimers Dis 34: 155-170.
33. Arita M, Ohira T, Sun YP, Elangovan S, Chiang N, et al. (2007) Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation. J Immunol 178: 3912-3917.
34. Ollivier V, Parry GC, Cobb RR, de Prost D, Mackman N (1996) Elevated cyclic AMP inhibits NF-kappaB-mediated transcription in human monocytic cells and endothelial cells. J Biol Chem 271: 20828-20835.
35. Oldenburger A, Roscioni SS, Jansen E, Menzen MH, Halayko AJ, et al. (2012) Anti-inflammatory role of the cAMP effectors Epac and PKA: implications in chronic obstructive pulmonary disease. PLoS One 7: e31574.
36. Pober JS, Slowik MR, De Luca LG, Ritchie AJ (1993) Elevated cyclic AMP inhibits endothelial cell synthesis and expression of TNF-induced endothelial leukocyte adhesion molecule-1, and vascular cell adhesion molecule-1, but not intercellular adhesion molecule-1. J Immunol 150: 5114-5123.
37. Ghersa P, Hooft van Huijsduijnen R, Whelan J, Cambet Y, Pescini R, et al. (1994) Inhibition of E-selectin gene transcription through a cAMP-dependent protein kinase pathway. J Biol Chem 269: 29129-29137.
38. Panettieri RA, Jr., Lazaar AL, Pure E, Albelda SM (1995) Activation of cAMPdependent pathways in human airway smooth muscle cells inhibits TNF-alphainduced ICAM-1 and VCAM-1 expression and T lymphocyte adhesion. J Immunol 154: 2358-2365.
39. Claria J, Nguyen BT, Madenci AL, Ozaki CK, Serhan CN (2013) Diversity of lipid mediators in human adipose tissue depots. Am J Physiol Cell Physiol 304: C1141-1149.
40. Le Faouder P, Baillif V, Spreadbury I, Motta JP, Rousset P, et al. (2013) LCMS/ MS method for rapid and concomitant quantification of pro-inflammatory and pro-resolving polyunsaturated fatty acid metabolites. J Chromatogr B Analyt Technol Biomed Life Sci 932: 123-133.